Drugs News and Research

RSS

Researchers create new brain cancer model using genetically engineered pluripotent stem cells

Using genetically engineered human pluripotent stem cells, University of California San Diego School of Medicine researchers created a new type of cancer model to study in vivo how glioblastoma, the most common and aggressive form of brain cancer, develops and changes over time.

29 Jan 2020

60+ organizations to speak as the NASH Summit Boston returns

Hansonwade will present the 4th NASH Summit in Boston from May 4-7, 2020. For its anticipated return, the forum is set to widen its program and congregate over 350+ industry stakeholders for presentations from global regulatory agencies and leading biopharma.

From 4th NASH Summit Boston 29 Jan 2020

FDA issues stern warning to Purell hand sanitizer maker

The U.S. Food and Drug Administrator has issued a strict warning to Purell-maker GOJO Industries, which claims it hand sanitizers can kill pathogens that cause illness in as little as 15 seconds.

29 Jan 2020

New guidance will help improve outcomes for patients with hyperthyroidism

Radioactive iodine is to be recommended as the frontline treatment for patients with thyroid gland overactivity caused by conditions such as Graves’ disease, following an evidence review led by University of Birmingham researchers.

28 Jan 2020

Why new cancer drugs take so long to reach the market

A new analysis of cancer drug development by researchers at the Institute of Cancer Research, London, shows that the more revolutionary a new cancer drug is, the longer it takes to reach patients in the UK’s National Health Service healthcare system. In other words, refinements on earlier drugs or drugs which are more conventional in their effects make it to the marketplace faster

28 Jan 2020

Researchers discover a defense mechanism that protects cells from microbial attacks

Human cells have a defense mechanism that protects them from microbial attacks, a Canadian-led team of international researchers has discovered.

28 Jan 2020

Bone marrow chip provides new strategy for understanding Shwachman-Diamond syndrome

A new research tool that mimics the behavior of diseased bone marrow provides a new strategy for understanding the bone marrow disease, Shwachman-Diamond syndrome, and hopefully, developing new treatments.

28 Jan 2020

Successful gene therapy trial in patients with X-linked Chronic Septic Granulomatosis

American and British teams led by Drs Kohn (University of California, Los Angeles), Malech (NIH), Williams (Boston Children's) and Trasher (Great Ormond Street Institute of Child Health) published yesterday in Nature Medicine the conclusive results of a gene therapy trial conducted in the United States and Great Britain in 9 patients with X-linked Chronic Septic Granulomatosis (X-CGD), a rare and severe immune dysfunction. Six of them are free of treatment for complications generated by the disease.

28 Jan 2020

The challenge of new antibiotic discovery

It is important to discover antibiotic drugs and to bring them to clinical use, a task made all the more urgent by the increase in the number of infections that are resistant to existing antibiotics. However, this task is a formidable one.

28 Jan 2020

Novel palladium compound acts against ovarian tumor cells

A group led by a researcher affiliated with the University of São Paulo's São Carlos Chemistry Institute (IQSC-USP) in Brazil has developed a novel palladium compound that acts against ovarian tumor cells without affecting healthy tissues. Palladium is a silvery white metal belonging to the same group as platinum.

28 Jan 2020

Researchers discover how CDK8 oncogene gets activated in healthy humans

Most cancers are caused by a large variety of factors that vary from one person to another. To unravel this complexity, genes that contribute to the development of a respective cancer must be identified. Such genes are called oncogenes. A good example of an oncogene is CDK8: Cyclin-dependent kinase 8.

28 Jan 2020

New study of genes in Asian populations may help better understand, treat genetic diseases

An ambitious new study of genes in Asian populations is filling in big gaps in our understanding of human genetics, shedding light on the history of human migration and ultimately aiming to improve our ability to treat disease.

28 Jan 2020

Non-invasive electrostimulation of the vagus nerve improves memory in mice

Researchers at UPF are testing a new non-invasive method of stimulating the vagus nerve in mice that improves their memory.

28 Jan 2020

New AI tool predicts disease progression and evolution in neurodegenerative disorders

Researchers have found that testing blood using an artificial intelligence algorithm successfully predicted disease progression in neurodegenerative disorders.

28 Jan 2020

Psychedelic drug has enduring antianxiety and antidepressant effects in cancer patients

Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy appears to be associated with significant improvements in emotional and existential distress in cancer patients.

28 Jan 2020

AI analysis of blood samples can predict progression of neurodegenerative disease

Evaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient's progression is different.

28 Jan 2020

Conceived through ‘fertility fraud,’ she now needs fertility treatment

When Heather Woock was in her late 20s, she started researching her family history. As part of the project, she spit into a tube and sent it to Ancestry, a consumer DNA testing service. Then, in 2017, she started getting messages about the results from people who said they could be half siblings.

28 Jan 2020

Human organ chips for better drug development

The process of developing new drugs is both difficult and costly. It is estimated that of all the drug candidates which start out on their testing journey, less than 14% actually make it to the clinical scene and receive approval by the US Food and Drug Administration (FDA).

27 Jan 2020

New micro-scale technology holds promise for improved tumor diagnosis

Using a single-needle biopsy and new technology for tumor diagnosis developed by Baylor College of Medicine and the Broad Institute of MIT and Harvard, researchers have been able to provide a more detailed and wider window into cancer biology, tumor type and the mechanisms of response and resistance to therapy than with conventional approaches.

27 Jan 2020

Study suggests prenatal origin for ‘young’ Parkinson’s disease

A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson’s disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.

27 Jan 2020

Drugs News and Research

Researchers create new brain cancer model using genetically engineered pluripotent stem cells

60+ organizations to speak as the NASH Summit Boston returns

FDA issues stern warning to Purell hand sanitizer maker

New guidance will help improve outcomes for patients with hyperthyroidism

Why new cancer drugs take so long to reach the market

Researchers discover a defense mechanism that protects cells from microbial attacks

Bone marrow chip provides new strategy for understanding Shwachman-Diamond syndrome

Successful gene therapy trial in patients with X-linked Chronic Septic Granulomatosis

The challenge of new antibiotic discovery

Novel palladium compound acts against ovarian tumor cells

Researchers discover how CDK8 oncogene gets activated in healthy humans

New study of genes in Asian populations may help better understand, treat genetic diseases

Non-invasive electrostimulation of the vagus nerve improves memory in mice

New AI tool predicts disease progression and evolution in neurodegenerative disorders

Psychedelic drug has enduring antianxiety and antidepressant effects in cancer patients

AI analysis of blood samples can predict progression of neurodegenerative disease

Conceived through ‘fertility fraud,’ she now needs fertility treatment

Human organ chips for better drug development

New micro-scale technology holds promise for improved tumor diagnosis

Study suggests prenatal origin for ‘young’ Parkinson’s disease

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News